Health Professional Radio - Podcast

Incyte, a global biopharmaceutical company announces its opening call for submissions for its new Incyte Ingenuity Award. a program created to support people living with graft-versus-host disease (GVHD), as well as their caregivers and physicians. GVHD is a potentially life-threatening condition that can occur after a stem cell or bone marrow transplant from a donor initiate an immune response and attack the transplant recipient's organs. Here to talk about Incyte's dedication to the program is Incyte's Executive Vice President, General Manager, United States, Dr. Barry Flannelly. The program is expected to fund up to $100,000 a year for one innovative program or idea.